Srishti Saha1, Saloni Kapoor1, Raseen Tariq1, Audrey N Schuetz2, Pritish K Tosh3, Darrell S Pardi1, Sahil Khanna4. 1. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, 55905, USA. 2. Division of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA. 3. Division of Infectious Diseases, Mayo Clinic, Rochester, MN, 55905, USA. 4. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: khanna.sahil@mayo.edu.
Abstract
BACKGROUND: Decreases in clinical response of Clostridioides difficile to antibiotics used for its treatment have raised concerns regarding antibiotic resistance. We conducted a systematic review and meta-analysis to study the resistance rates of C. difficile to various antibiotics over time. METHODS: We systematically searched MEDLINE, Embase, and Web of Science from inception through 03/31/2017 for observational studies assessing antibiotic resistance rates in C. difficile. Weighted summary estimates were calculated using inverse variance heterogeneity models [MetaXL software (v. 5.3)]. A priori subgroup analyses were done (by study year, continent, susceptibility testing method, origin of isolates); ribotype 027 strains were analyzed separately. RESULTS: From 1982 to 2017, 60 studies (8336 isolates) were analyzed. Fifty-three studies reported vancomycin resistance; weighted pooled resistance (WPR), 2.1% (95% CI, 0%-5.1%; I2 = 95%). Fifty-five studies reported metronidazole resistance; WPR, 1.9% (95% CI, 0.5%-3.6%; I2 = 89%). Compared to the period before 2012, vancomycin resistance increased by 3.6% (95% CI, 2.9%-4.2%; P < 0.001) after 2012, and metronidazole resistance decreased by 0.8% (95% CI, 0.1%-1.5%; P = 0.02). No isolates were resistant to fidaxomicin. CONCLUSION: Resistance of C. difficile to vancomycin is increasing, with a smaller, declining resistance to metronidazole; there is significant heterogeneity between studies. Ongoing monitoring of resistance to commonly used antibiotics is required.
BACKGROUND: Decreases in clinical response of Clostridioides difficile to antibiotics used for its treatment have raised concerns regarding antibiotic resistance. We conducted a systematic review and meta-analysis to study the resistance rates of C. difficile to various antibiotics over time. METHODS: We systematically searched MEDLINE, Embase, and Web of Science from inception through 03/31/2017 for observational studies assessing antibiotic resistance rates in C. difficile. Weighted summary estimates were calculated using inverse variance heterogeneity models [MetaXL software (v. 5.3)]. A priori subgroup analyses were done (by study year, continent, susceptibility testing method, origin of isolates); ribotype 027 strains were analyzed separately. RESULTS: From 1982 to 2017, 60 studies (8336 isolates) were analyzed. Fifty-three studies reported vancomycin resistance; weighted pooled resistance (WPR), 2.1% (95% CI, 0%-5.1%; I2 = 95%). Fifty-five studies reported metronidazole resistance; WPR, 1.9% (95% CI, 0.5%-3.6%; I2 = 89%). Compared to the period before 2012, vancomycin resistance increased by 3.6% (95% CI, 2.9%-4.2%; P < 0.001) after 2012, and metronidazole resistance decreased by 0.8% (95% CI, 0.1%-1.5%; P = 0.02). No isolates were resistant to fidaxomicin. CONCLUSION: Resistance of C. difficile to vancomycin is increasing, with a smaller, declining resistance to metronidazole; there is significant heterogeneity between studies. Ongoing monitoring of resistance to commonly used antibiotics is required.
Authors: Meng Pu; Janice M Cho; Scott A Cunningham; Gaurav K Behera; Sarah Becker; Talal Amjad; Kerryl E Greenwood-Quaintance; Helena Mendes-Soares; Yava Jones-Hall; Patricio R Jeraldo; Jun Chen; Gary Dunny; Robin Patel; Purna C Kashyap Journal: Gastroenterology Date: 2020-11-14 Impact factor: 22.682
Authors: Ariana Saatchi; Andrew M Morris; David M Patrick; James Mccormack; Romina C Reyes; Phillip Morehouse; Jennifer Reid; Salimah Shariff; Marcus Povitz; Michael Silverman; Fawziah Marra Journal: JAC Antimicrob Resist Date: 2021-08-12
Authors: Anne J Gonzales-Luna; Jennifer K Spinler; Numan Oezguen; Md Abdul Wadud Khan; Heather A Danhof; Bradley T Endres; M Jahangir Alam; Khurshida Begum; Chris Lancaster; Gabriela Pd Costa; Tor C Savidge; Julian G Hurdle; Robert Britton; Kevin W Garey Journal: Anaerobe Date: 2021-05-24 Impact factor: 2.837